Foxp3+ Tregs in IBD patients are more likely to co-express the cytokines and transcription factors of the effector subtypes [38,39]; hence, the restoration of the stable Foxp3-expressing Treg population can be successful in alleviating IBD. Here, FOXP3 is linked to inflammatory bowel disease.